Specifically, individuals with Alzheimer’s disease that also express high levels of ankyrin G in frontal cortex and elevated levels of ankyrin G antibodies in serum exhibit significantly reduced cognitive decline than individuals with significantly lower ankyrin G serum antibody levels [125]. The gene discussed is ANK3; the disease is early-onset autosomal dominant Alzheimer disease.